tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRBP Stock Latest News

Corbus Pharmaceuticals: Promising Clinical Programs and Strong Financial Position Drive Buy Rating
RatingsCorbus Pharmaceuticals: Promising Clinical Programs and Strong Financial Position Drive Buy Rating
9d ago
CRBP
Corbus Pharmaceuticals: Promising Pipeline and Strategic Advancements Justify Buy Rating
PremiumRatings
Corbus Pharmaceuticals: Promising Pipeline and Strategic Advancements Justify Buy Rating
10d ago
CRBP
Corbus Pharmaceuticals price target lowered to $53 from $56 at Oppenheimer
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $53 from $56 at Oppenheimer
10d ago
CRBP
Corbus Pharmaceuticals Reports Q2 2025 Financials and Updates
PremiumCompany Announcements
Corbus Pharmaceuticals Reports Q2 2025 Financials and Updates
11d ago
CRBP
Corbus Pharmaceuticals: Promising Outlook with Key Data Releases and Strong Financial Position
PremiumRatings
Corbus Pharmaceuticals: Promising Outlook with Key Data Releases and Strong Financial Position
11d ago
CRBP
Corbus Pharmaceuticals Receives FDA Fast Track Designation
PremiumCompany AnnouncementsCorbus Pharmaceuticals Receives FDA Fast Track Designation
11d ago
8K
CRBP
Corbus Pharmaceuticals reports Q2 EPS ($1.44), consensus ($1.33)
Premium
The Fly
Corbus Pharmaceuticals reports Q2 EPS ($1.44), consensus ($1.33)
11d ago
CRBP
Corbus Pharmaceuticals transferred with Buy rating at B. Riley
Premium
The Fly
Corbus Pharmaceuticals transferred with Buy rating at B. Riley
17d ago
CRBP
Corbus announces presentation of dose expansion Phase 1/2 data for CRB-701
PremiumThe Fly
Corbus announces presentation of dose expansion Phase 1/2 data for CRB-701
17d ago
CRBP
Corbus Pharmaceuticals initiates MAD portion of its Phase 1 trial for CRB-913
PremiumThe Fly
Corbus Pharmaceuticals initiates MAD portion of its Phase 1 trial for CRB-913
2M ago
CRBP
Corbus says first patient dosed in PD-1 combo arm of Phase 1 study of CRB-701
PremiumThe Fly
Corbus says first patient dosed in PD-1 combo arm of Phase 1 study of CRB-701
2M ago
CRBP
Corbus Pharmaceuticals: Strategic Positioning and Promising Pipeline Drive Buy Rating
PremiumRatings
Corbus Pharmaceuticals: Strategic Positioning and Promising Pipeline Drive Buy Rating
2M ago
CRBP
Buy Rating for Corbus Pharmaceuticals’ CRB-701: Promising Efficacy and Safety in Oncology
PremiumRatingsBuy Rating for Corbus Pharmaceuticals’ CRB-701: Promising Efficacy and Safety in Oncology
3M ago
CRBP
Corbus Pharmaceuticals Appoints New Chair of the Board
Premium
Company Announcements
Corbus Pharmaceuticals Appoints New Chair of the Board
3M ago
8K
CRBP
Corbus Pharmaceuticals appoints Jacques as Chair of Board of Directors
Premium
The Fly
Corbus Pharmaceuticals appoints Jacques as Chair of Board of Directors
3M ago
CRBP
Corbus Pharmaceuticals price target lowered to $28 from $40 at B. Riley
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $28 from $40 at B. Riley
3M ago
CRBP
Corbus Pharmaceuticals price target lowered to $58 from $65 at RBC Capital
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $58 from $65 at RBC Capital
3M ago
CRBP
Corbus Pharmaceuticals price target lowered to $56 from $60 at Oppenheimer
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $56 from $60 at Oppenheimer
3M ago
CRBP
Corbus Pharmaceuticals price target lowered to $40 from $50 at H.C. Wainwright
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $40 from $50 at H.C. Wainwright
3M ago
CRBP
Corbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss
PremiumCompany AnnouncementsCorbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss
3M ago
CRBP
Corbus Pharmaceuticals Receives FDA Fast Track Designation
Premium
Company Announcements
Corbus Pharmaceuticals Receives FDA Fast Track Designation
3M ago
8K
CRBP
Corbus Pharmaceuticals reports Q1 EPS ($1.39), consensus ($1.07)
Premium
The Fly
Corbus Pharmaceuticals reports Q1 EPS ($1.39), consensus ($1.07)
3M ago
CRBP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >